Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 6 mg/ml (equivalent: salbutamol, qty 5 mg/ml) - inhalation - excipient ingredients: purified water; benzalkonium chloride; sulfuric acid - indications as at 1st february 1999: for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma or in other situations known to induce bronchospasm.

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - tretinoin, quantity: 0.5 mg/g - cream - excipient ingredients: propylene glycol; purified water; peg-40 stearate; white soft paraffin; propyl hydroxybenzoate; disodium edetate; stearyl alcohol; stearic acid; methyl hydroxybenzoate; butylated hydroxytoluene; isopropyl palmitate; butylated hydroxyanisole - indicated for use in the treatment of acne vulgaris, in particular forms where comedones, papules and pustules predominate.

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - tretinoin, quantity: 0.25 mg/g - cream - excipient ingredients: methyl hydroxybenzoate; propylene glycol; propyl hydroxybenzoate; white soft paraffin; purified water; stearic acid; peg-40 stearate; butylated hydroxyanisole; butylated hydroxytoluene; stearyl alcohol; isopropyl palmitate; disodium edetate - indicated for use in the treatment of acne vulgaris, in particular forms where comedones, papules and pustules predominate.

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - retapamulin -

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - haemophilus influenza type b polyribose ribitol phosphate,meningococcal polysaccharide group c,tetanus toxoid -

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - pneumococcal purified capsular polysaccharides -

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - clobetasone butyrate, quantity: 0.5 mg/g - cream - excipient ingredients: citric acid monohydrate; chlorocresol; purified water; glycerol; cetostearyl alcohol; glyceryl monostearate; sodium citrate dihydrate; peg-100 stearate; stearic acid; carnauba wax; hard paraffin - short-term (up to 7 days) treatment of milder forms of eczema, dermatitis and other steroid responsive skin conditions.

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - tetanus toxoid, quantity: 40 microgram/ml; haemophilus influenza type b polyribose ribitol phosphate, quantity: 20 microgram/ml - injection, powder for - excipient ingredients: water for injections; sodium chloride; lactose - hiberix is indicated for active immunisation against haemophilus influenzae type b infection in children aged from 2 months to 5 years.

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - podophyllotoxin -

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 0.48 mg/ml (equivalent: salbutamol, qty 0.4 mg/ml) - oral liquid - excipient ingredients: sodium benzoate; hypromellose; citric acid monohydrate; sodium chloride; purified water; sodium citrate dihydrate; saccharin sodium; flavour - indications as at 14 february 2005: ventolin is indicated for the prevention and relief of bronchospasm in bronchial asthma of all types and for the alleviation of any reversible airways obstruction associated with conditions such as chronic bronchitis or emphysema.